Trials / Conditions / Pancreatic Neuroendocrine Tumor G1

Pancreatic Neuroendocrine Tumor G1

3 registered clinical trials studyying Pancreatic Neuroendocrine Tumor G1 — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreati NCT06016855	Vanderbilt-Ingram Cancer Center	Phase 4
Completed	Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be NCT02893930	National Cancer Institute (NCI)	Phase 2
Completed	Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Me NCT01229943	National Cancer Institute (NCI)	Phase 2